focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksShire Share News (SHP)

  • There is currently no data for SHP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

FOREX-Dollar edges up as US yields poke above 3 percent to 4-year highs

Wed, 25th Apr 2018 04:19

* Dollar index edges up towards 4-month highs

* 10-yr US yield pokes above 3 pct for first time sinceearly 2014

* Widening yield spreads seen supporting dollar long term

* Kiwi extends drop, at its lowest since early January(Updates throughout)

By Shinichi Saoshiro

TOKYO, April 25 (Reuters) - The dollar inched up onWednesday, approaching its recent four-month high as the U.S.10-year bond yield poked above 3 percent to hit its highestlevel since early 2014.

The dollar index against a basket of six major currenciesrose 0.1 percent to 90.844. It had climbed overnight to91.016, highest since Jan. 12, before a slide in Wall Streetstocks tempered investor risk appetite and slowed thegreenback's rally against its peers, notably the yen.

The greenback had risen without pause through much of thepast week as U.S.-China trade conflict woes receded and allowedthe market to turn its attention back to dollar-supportivefundamentals, notably the surge by U.S. yields.

"Revived expectations that the U.S. economy would performwell thanks to tax cuts and increased fiscal spending aresupporting the dollar," said Shin Kadota, senior strategist atBarclays in Tokyo.

"Yields rose and equities slipped before but the situationis a little different, as expectations towards the U.S. economyare now stronger," Kadota said.

Tuesday's data on U.S. consumer confidence and new homesales, both stronger in April, bolstered the case that theworld's biggest economy will continue to grow in the comingquarters.

The U.S. currency was 0.1 percent higher at 108.900 yen. It pulled back from a 2-1/2-month high of 109.200 setthe previous day when the S&P 500 and the Dowposted their biggest declines since April 6.

While the weakening by equities was supportive for the yen,often sought when stocks fall due to its perceived safe-havenstatus, analysts said the dollar was still likely headed forfurther gains in the longer-term.

"At first glance, the situation is similar to February, whenU.S. yields rose sharply and equities tumbled. But thedifference this time is that the response by equities is moremeasured, and yen demand stemming from 'risk off' is not nearlyas strong," said Yukio Ishizuki, senior currency strategist atDaiwa Securities in Tokyo.

"The market's attention is firmly back on interest ratedifferentials and this is likely to keep supporting the dollargoing forward."

The spreads between U.S. yields and those of its Europeanand Japanese counterparts have widened significantly amiddiverging monetary policy expectations.

This week the gap between U.S. and German 10-year governmentbond yields has hit its widest in 29 years and the U.S.-Japanese10-year yield spread reached its broadest in nearly 11 years.

The 10-year Treasury yield extended itsovernight rise and touched the four-year peak of 3.009 percent,reflecting the durability of the U.S. economic expansion.Accelerating inflation and concerns about increasing debt supplyhave also driven yields higher.

Wall Street dropped sharply on Tuesday as warnings bybellwether companies of higher costs stemming from the surge inyields reverberated.

The pound was effectively flat at $1.3981. Itplumbed a one-month low of $1.3919 on Tuesday before rebounding0.3 percent, seen to have been supported in part by news about apossible takeover of British pharmaceutical company Shire Plcby Japanese drugmaker Takeda Pharmaceutical Co.

The Australian dollar shed 0.2 percent to $0.7586and in close reach of a four-month trough of $0.7576 plumbed theprevious day.

The New Zealand dollar extended losses and dipped to $0.7102, its weakest since Jan. 4.

The kiwi, on track for its seventh session of losses, hasslumped 2 percent this month.

The currency has faced pressure from a resurgent dollar andalso by increasing expectations that the Reserve Bank of NewZealand would hold off from raising rates through 2018 afterdata last week showed the country's inflation nearing the bottomof the central bank's target.(Reporting by Shinichi SaoshiroEditing by Sam Holmes)

More News
30 Nov 2018 07:38

LONDON MARKET PRE-OPEN: Ecolab To Acquire Bioquell For GBP141 Million

LONDON (Alliance News) - Stock prices in London are seen opening marginally lower on Friday as investors await a meeting of US and Chinese leaders at the G20 summit.IG futures indicate the FTSE is

Read more
30 Nov 2018 07:23

Shire gets EC approval for hereditary angioedema jab

(Sharecast News) - Shire's injectable treatment for hereditary angioedema (HAE) has been cleared for launch in European, having enjoyed early success in the US.

Read more
28 Nov 2018 07:53

Shire's Lanadelumab Help Study Meets Primary And Secondary Endpoints

LONDON (Alliance News) - Shire PLC said Tuesday it has published the full results of its phase III Help study of its hereditary angioedema drug Lanadelumab showing that the study met all of its is

Read more
20 Nov 2018 14:34

EU clears Takeda's Shire acquisition on divestment condition

(Sharecast News) - The European Commission has cleared Takeda Pharmaceutical's £46bn acquisition of Shire, subject to the divestment of a bowel disease drug under development by Shire.

Read more
1 Nov 2018 12:48

TOP NEWS: Shire Revenue Climbs On Strong Performance From Immunology

LONDON (Alliance News) - Shire PLC on Thursday updated its guidance and said its revenue grew in the third quarter of of 2018 as a result of strong Immunology division growth, recent product and a

Read more
1 Nov 2018 12:09

Shire sales remain solid, Takeda deal 'on track'

(Sharecast News) - Shire Pharmaceuticals, the subject of a $62bn takeover by Japan's Takeda, said its focus on rare diseases had offset foreign exchange weakness and boosted third-quarter profits.

Read more
1 Nov 2018 08:48

LONDON MARKET OPEN: Oil Stocks And Strong Pound Weigh On FTSE 100

LONDON (Alliance News) - Stocks in London opened mixed on Thursday, with heavyweight oil majors and a stronger pound hampering the FTSE 100, ahead of the Bank of England's interest rate decion

Read more
31 Oct 2018 06:11

Takeda's raises full-year outlook after Q2 profit rise

TOKYO, Oct 31 (Reuters) - Takeda Pharmaceutical Co Ltd on Wednesday raised its annual operating profit outlook to 268.9 billion yen. That compares with an earlier company estimate of yen an

Read more
29 Oct 2018 12:19

Takeda proposes selling off Shire drug to gain merger clearance

(Sharecast News) - Takeda Pharmaceuticals may need to sell off one of Shire's pipeline drugs in order to gain European regulatory clearance for the agreed $62bn takeover.

Read more
29 Oct 2018 12:19

Takeda proposes selling off Shire drug to gain merger clearance

(Sharecast News) - Takeda Pharmaceuticals may need to sell off one of Shire's pipeline drugs in order to gain European regulatory clearance for the agreed $62bn takeover.

Read more
29 Oct 2018 10:51

WINNERS & LOSERS SUMMARY: HSBC Rises After Upbeat Third Quarter

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Monday.----------FTSE 100 - WINNERS----------HSBC,

Read more
29 Oct 2018 07:35

LONDON MARKET PRE-OPEN: Better-Than-Expected HSBC To Lift FTSE 100

LONDON (Alliance News) - Stocks in London are set to open on firmer ground on Monday, following last week's sell-off, while traders eye Chancellor Philip Hammond's UK government shares in in

Read more
26 Oct 2018 07:52

Takeda Secures JPY1 Trillion Of Financing To Help Shire Deal

LONDON (Alliance News) - Japan's Takeda Pharmaceuticals Inc on Friday said it has secured new financing to help it with its acquisition of FTSE 100 member Shire PLC.The new short-term a

Read more
25 Oct 2018 16:21

Shire hopes to get green light for US Flexbumin manufacture

(Sharecast News) - Shire on Thursday filed a submission to the US food and drug administration to gain approval to manufacture Flexbumin at its new facility in the state of Georgia.

Read more
25 Oct 2018 16:03

UK Earnings, Trading Statements Calendar - Next 7 Days

Friday 26 October GlencoreQ3 ProductionInternational Consolidated Airlines GroupQ3 Bank 1

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.